<DOC>
	<DOCNO>NCT01484665</DOCNO>
	<brief_summary>Decision-aids tool educate patient give topic may better participate shared-decision make health care . Given complexity associate PSA test , many professional organization advocate shared-decision making PSA testing . However , consensus exist best educate involve patient shared-decision make process . The goal study evaluate pilot program utilizing simple PSA screen decision-aid present two different fashion primary care clinic large fraction African-American patient . The investigator evaluate effectiveness program educate patient risk benefit prostate specific antigen ( PSA ) testing , subsequent level comfort decision whether receive PSA testing , comfort level physicians patient 's decision regard PSA testing , importantly , well strategy implement daily work-flow clinic . If successful , program may serve model broad implementation strategy across Minnesota country .</brief_summary>
	<brief_title>Evaluating Effect Decision Aid Shared Decision Making Prostate Cancer Screening</brief_title>
	<detailed_description>This pilot project evaluate two approach implement use simple print PSA screen decision-aid ( DA ) administer urban primary care clinic populate significant number African-Americans . All subject complete survey assess knowledge attitude PSA screen share decision making ( SDM ) , physician also briefly queried perception SDM process . After first three month implementation period conduct focus group clinic staff guide change refinement use DA clinical setting . Another three month implementation period follow use method assess outcomes . Finally conduct another round focus group assess overall impact intervention .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Inclusion criterion : Males age 5075 Able read speak English Provide write informed consent Exclusion criterion : Diagnosis prostate cancer PSA test within last 12 month Previous prostate biopsy Voiding problem reason clinic visit Visit schedule day 'walkIn ' patient</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>PSA screening</keyword>
	<keyword>Decision aid</keyword>
</DOC>